Conformité du traitement pharmacologique et une description de ses facteurs associés chez les patients atteints de MG

Rubrique ouverte à tous en lecture seule.
POUR ACCEDER AUX NOMBREUX AUTRES FORUMS IL EST NECESSAIRE DE S'INSCRIRE (fonction M'enregistrer en haut à droite de l'écran).
Répondre
Avatar du membre

Auteur du sujet
Pboulanger
Administrateur
Administrateur
Messages : 5162
Enregistré le : 02 févr. 2010 18:41
Localisation : La Chapelle en Serval F-60520
    Windows 10 Firefox
Genre :
Zodiaque :
Âge : 61
Contact :
France

Conformité du traitement pharmacologique et une description de ses facteurs associés chez les patients atteints de MG

Message par Pboulanger » 20 déc. 2017 18:39

:hi:

:arrow: Lu sur :https://www.ncbi.nlm.nih.gov/pubmed/29251338

Traduction disponible directement en cliquant en bas à droite de ce message sur notre forum

Image

Pharmacological treatment compliance and a description of its associated factors in patients with myasthenia gravis
[Article in Spanish; Abstract available in Spanish from the publisher]
Idiaquez JF1,2, Gonzalez S1,2, Lasso-Penafiel J1, Barnett C3.
Rev Neurol. 2018 Jan 1;66(1):15-20.


Abstract
  • INTRODUCTION:

    Medication adherence is a public health problem and this has not been previously studied in myasthenia gravis patients.
    AIM:

    To determine if patients with myasthenia gravis are adherent to treatment and to describe the clinical factors of patients who are non-adherent to treatment.
  • PATIENTS AND METHODS:

    Cross-sectional study of patients with myasthenia gravis followed at Padre Hurtado Hospital, Santiago de Chile, who received their medication through the hospital and therefore were on the pharmacy's list. Patients' participation was voluntary and anonymous. Medication adherence was assessed with the Morisky-Green-Levine survey (4 items). Patients were assessed for myasthenia gravis severity with the Manual Muscle Test, and myasthenia gravis-related quality of life with the MG-QOL15. Finally, patients were screened for depression with the 12-Item General Health Questionnaire.
  • RESULTS:

    26 patients were enrolled and 15 (57.7%) were women. Only 10 (38.5%) of patients were adherent to treatment. Patients who were not adherent to medication had more weakness (p = 0.06), worse quality of life (p = 0.008), were taking a greater number of myasthenia gravis drugs (p = 0.003) and had a higher risk of depression (p = 0.03).
  • CONCLUSIONS:

    In this cohort of myasthenia gravis patients, three out of five patients were not adherent to treatment. These patients tended to have more weakness, worse quality of life and higher risk of depression. Medication adherence should be assessed routinely in patients with myasthenia gravis.
Lien vers Google Trad https://translate.google.fr/translate?h ... 2F29251338
Message de : Pboulanger  un membre de l'équipe technique
Nous utilisons un service automatique de traduction fourni par YANDEX.
Soyez vigilant sur le risque de contre-sens inhérent à ce genre d'outils.
Amicalement,
Image

Répondre

Retourner vers « Informations »